{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hepatocellular-carcinoma","columns":[{"gene":"","key":"population-e1f5836fa149935825d2","label":"Hepatocellular carcinoma","mondoId":"MONDO:0007256","onsetQualifier":null,"originColumnKey":"MONDO:0007256/OMIM:114550","originalViews":[{"key":"MONDO:0007256/OMIM:114550","label":"Hepatocellular carcinoma","scopeLabel":"OMIM:114550","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["6cd0daca18f2e1e1cc1c36def9337043cd4d22112410d89f4e8eab98c1519d2b","83e7e33f0f9bea7a733134f45e9857f737ae6dc30893a719c2446f32f037b08c","8c94c6d7df7c06b2cf096e374744c6c5a39ba797cb2d340429da2593d9306b7a"],"recordQualifiers":{},"scopeLabel":"OMIM:114550","sourceIds":["OMIM:114550"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e1f5836fa149935825d2"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001402","HP:0001413","HP:0006572"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"omim":3}},"features":[{"hpoId":"HP:0001402","label":"Hepatocellular carcinoma","primary":true},{"hpoId":"HP:0001413","label":"Micronodular cirrhosis","primary":true},{"hpoId":"HP:0006572","label":"Subacute progressive viral hepatitis","primary":true}],"ledeHtml":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","mondoId":"MONDO:0007256","node":{"canonicalSlug":"hepatocellular-carcinoma","comparisons":[{"documentSha256":"d5d1cb6528219a392fb10c211bf3841ebc024680d82cb0d47281eb7a826d0718","key":"legacy-carcinoma-of-liver-and-intrahepatic-biliary-tract","kind":"legacy","label":"carcinoma of liver and intrahepatic biliary tract","memberIds":["MONDO:0007256","MONDO:0018055","MONDO:0018531"],"mondoId":"MONDO:0018531","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/carcinoma-of-liver-and-intrahepatic-biliary-tract.d5d1cb6528219a392fb10c211bf3841ebc024680d82cb0d47281eb7a826d0718.json"},{"documentSha256":"7c4f23f29b9b7fc1ab8826add26305486810e7e09eb86cee00d12aa79cd69e6d","key":"expanded-carcinoma-of-liver-and-intrahepatic-biliary-tract","kind":"expanded","label":"carcinoma of liver and intrahepatic biliary tract","memberIds":["MONDO:0000891","MONDO:0003210","MONDO:0003243","MONDO:0003245","MONDO:0003246","MONDO:0003650","MONDO:0003651","MONDO:0004078","MONDO:0004315","MONDO:0004346","MONDO:0004451","MONDO:0004715","MONDO:0006210","MONDO:0006268","MONDO:0007256","MONDO:0015072","MONDO:0016216","MONDO:0018055","MONDO:0018531","MONDO:0018533","MONDO:0018534","MONDO:0018535","MONDO:0018666","MONDO:0044788","MONDO:0044791","MONDO:0056815","MONDO:0100132"],"mondoId":"MONDO:0018531","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-7c4f23f29b9b7fc1ab88.7c4f23f29b9b7fc1ab8826add26305486810e7e09eb86cee00d12aa79cd69e6d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hepatocellular carcinoma","originalSourceId":"ORPHA:88673","paragraphs":["A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation."],"rawAttribution":"MONDO:0007256","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:05Z","upstream":"MONDO:0007256","url":"https://rarediseases.info.nih.gov/diseases/16773"},"ownColumnKeys":["population-e1f5836fa149935825d2"],"publication":"published","relationships":[{"kind":"parent","label":"adenocarcinoma","mondoId":"MONDO:0004970","slug":null},{"kind":"parent","label":"carcinoma of liver and intrahepatic biliary tract","mondoId":"MONDO:0018531","slug":"carcinoma-of-liver-and-intrahepatic-biliary-tract"},{"kind":"child","label":"hepatocellular clear cell carcinoma","mondoId":"MONDO:0003243","slug":"hepatocellular-clear-cell-carcinoma"},{"kind":"child","label":"aflatoxin-related hepatocellular carcinoma","mondoId":"MONDO:0003245","slug":null},{"kind":"child","label":"sclerosing hepatic carcinoma","mondoId":"MONDO:0003246","slug":"sclerosing-hepatic-carcinoma"},{"kind":"child","label":"fibrolamellar hepatocellular carcinoma","mondoId":"MONDO:0006210","slug":"fibrolamellar-hepatocellular-carcinoma"},{"kind":"child","label":"liver diffuse large B-cell lymphoma","mondoId":"MONDO:0006268","slug":"liver-diffuse-large-b-cell-lymphoma"},{"kind":"child","label":"adult hepatocellular carcinoma","mondoId":"MONDO:0016216","slug":"adult-hepatocellular-carcinoma"},{"kind":"child","label":"pediatric hepatocellular carcinoma","mondoId":"MONDO:0018055","slug":"pediatric-hepatocellular-carcinoma"},{"kind":"child","label":"hepatoblastoma","mondoId":"MONDO:0018666","slug":"hepatoblastoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"6cd0daca18f2e1e1cc1c36def9337043cd4d22112410d89f4e8eab98c1519d2b","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:114550","disease_name":"Hepatocellular carcinoma","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001413","is_excluded":false,"label":"Micronodular cirrhosis","onset_id":null,"reference":"OMIM:114550","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"83e7e33f0f9bea7a733134f45e9857f737ae6dc30893a719c2446f32f037b08c","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:114550","disease_name":"Hepatocellular carcinoma","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001402","is_excluded":false,"label":"Hepatocellular carcinoma","onset_id":null,"reference":"OMIM:114550","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8c94c6d7df7c06b2cf096e374744c6c5a39ba797cb2d340429da2593d9306b7a","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:114550","disease_name":"Hepatocellular carcinoma","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0006572","is_excluded":false,"label":"Subacute progressive viral hepatitis","onset_id":null,"reference":"OMIM:114550","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16773\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007256\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0007256</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16773\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hepatocellular-carcinoma","sourceDocuments":[{"name":"GARD: Hepatocellular carcinoma","reviewed":null,"source_release":"2026-10-25T03:42:05Z","url":"https://rarediseases.info.nih.gov/diseases/16773"},{"name":"MONDO: hepatocellular carcinoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007256"}],"sourceNote":"","synonyms":["adult hepatoma","adult primary hepatocellular carcinoma","cancer, hepatocellular","carcinoma of liver","carcinoma of liver cells","carcinoma of the liver cells","carcinoma, hepatocellular, malignant","HCC","hepatoblastoma, somatic","hepatocellular adenocarcinoma","hepatocellular cancer","hepatocellular cancer, somatic","hepatocellular carcinoma","hepatocellular carcinoma, childhood type, somatic","hepatocellular carcinoma, somatic","hepatoma","liver carcinoma","liver cell cancer (hepatocellular carcinoma)","liver cell carcinoma","primary carcinoma of liver cells","primary carcinoma of the liver cells"],"takeawayHtml":"","title":"hepatocellular carcinoma"},"schemaVersion":1}
